1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

So quiet

Discussion in 'Aerie Pharma' started by anonymous, Jan 9, 2019 at 3:17 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Crickets
     

  2. anonymous

    anonymous Guest

    it should be clam .... before the the storm of launching Rocklatan. Trust me, shits about to get real. Let’s see how messed up the goals will be! A few things Aerie does well is forecast goals, and launch products.
     
  3. anonymous

    anonymous Guest

    Reps who blew out their #'s and got paid $4 per script will hopefully at least get paid for their work this year. At least we will all have some managed care coverage in '19. Last year's comp plan was designed by some truly deranged psychos.
     
  4. anonymous

    anonymous Guest

    I’m striving this year to enhance my fitness and to always be learning new things this year, what are your goals?
     
  5. anonymous

    anonymous Guest

    To find a new job. I was hoping things would be improved for 2019 and while it’s marginally better it still sucks ass here.